Pages
Products
Human BMP2 adenoviral particles

Human BMP2 adenoviral particles

Cat.No. :  AD00127Z

Titer: ≥1x10^10 IFU/mL / ≥1x10^11 IFU/mL / ≥1x10^11 VP/mL / ≥1x10^12 VP/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Adenovirus Particle Information

Quality Control

Cat. No. AD00127Z
Target Gene BMP2
Product Type Adenoviral particle
Insert BMP2
Titer Varies lot by lot, for example, ≥1x10^10 IFU/mL, ≥1x10^11 IFU/mL, ≥1x10^11 VP/mL etc.
Size Varies lot by lot, for example, 250 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality adenovirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between adenovirus particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in adenovirus production, especially for applications in animal studies and gene therapy. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced adenovirus particles to ensure regulatory compliance.
Sterility Creative Biogene ensures that adenovirus products are free of any bacterial, fungal and other microbial contamination.
Ad5 E1 Detection All Creative Biogene adenoviruses are PCR tested to ensure that there are no detectable E1 sequences in the particles, which could be from revertants or external E1 contamination.
RCA Assays Adenovirus products originating at Creative Biogene are guaranteed to have undetectable replication-competent adenovirus (RCA). This quality control measure is important because there is always the possibility of wild-type contamination due to revertants or environmental sources.
PFU Titering All purified adenovirus preparations are tested for infectious titer. Creative Biogene's PFU test takes a few days longer but counts true plaques in HEK cells rather than estimating PFU titers via IHC staining or TCI50 of infected cells.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Bone morphogenetic protein 2 (BMP2), encoded by the BMP2 gene located on chromosome 20p12 in humans, is a key member of the transforming growth factor-β (TGF-β) superfamily. BMP2 is a powerful secreted signaling molecule that plays fundamental and non-redundant roles in embryonic skeletal development, postnatal bone growth, and the complex processes of bone repair and remodeling. BMP2 exerts its effects by binding to specific serine/threonine kinase receptors (BMPR-I and BMPR-II) on the surface of target cells. This binding triggers intracellular signaling cascades, primarily the classical Smad pathway (phosphorylation of Smad1/5/8, complex formation with Smad4, and nuclear translocation) and non-classical pathways (e.g., MAPK p38), which activate the transcription of key osteogenic genes. These genes include Runx2 (the master osteoblast transcription factor), Osterix (Osx), osteocalcin (OCN), and alkaline phosphatase (ALP). Thus, BMP2 is able to drive MSCs to differentiate into the osteoblast lineage, stimulate osteoblast differentiation and maturation, enhance extracellular matrix production, and ultimately promote the formation of mineralized bone nodules.

Human BMP2 adenoviral particles represent an advanced gene delivery platform that has been engineered to efficiently deliver human BMP2 directly into target cells in vitro or in vivo. These particles are based on the replication-defective human adenovirus type 5 (Ad5) and have been engineered to carry the full-length human BMP2 coding sequence. Key modifications include the deletion of essential early genes (E1 region and usually E3 region), rendering the virus unable to replicate in standard host cells and significantly improving safety. Inside the cell, the viral genome enters the nucleus but does not integrate into the host chromosome; instead, it remains episomal, resulting in stable, high-level but transient expression of the BMP2 transgene. This sustained, localized production of bioactive BMP2 protein in the target tissue microenvironment effectively mimics the natural paracrine/autocrine signals that are critical for bone formation, making adenoviral BMP2 delivery a powerful tool for studying osteogenesis.

The use of 3D printed gene-activated bone grafts represents a very promising approach in the dental and orthopedic fields. Bioresorbable poly-lactic-co-glycolic acid (PLGA) scaffolds infused with adenoviral constructs carrying genes for osteoinductive factors may offer an effective alternative to existing bone grafts for the reconstruction of large bone defects. Here, researchers aimed to confirm the in vitro and in vivo properties of 3D scaffolds composed of PLGA and adenoviral constructs carrying the BMP2 gene (Ad-BMP2). The elastic modulus of disc-shaped PLGA scaffolds created using a specialized 3D printer was determined by compression testing in both the axial and radial directions. In vitro cytocompatibility was assessed using adipose-derived stem cells (ADSCs). The ability of Ad-BMP2 to transduce cells was evaluated. The osteoinductive and biocompatibility properties of the scaffolds were also evaluated. The Young's modulus of the 3D printed PLGA scaffolds showed comparable values in both the axial and radial compression directions, with axial compression measured at 3.4 ± 0.7 MPa and radial compression measured at 3.17 ± 1.4 MPa. The scaffolds promoted cell adhesion and had no cytotoxic effects on ADSCs. Ad-BMP2 successfully transduced cells and induced osteogenic differentiation in vitro. In vivo studies demonstrated that the 3D printed PLGA scaffolds had osteoinductive properties and promoted bone formation within the scaffold filaments as well as in the center of the critical calvarial bone defect.

The osteoinductive and biocompatible properties were investigated by implantation into the critical defect of rat calvarial bone. After 56 days, bone tissue ingrowth was observed in or around the filaments of the PLGA+Ad-BMP2 scaffolds. After implantation of the plain PLGA scaffold connective tissue, macrophages migrated within the filaments, and no newly formed bone tissue was detected inside the material. It grew only from the edges of the defect. The center of the empty defect ("control") was filled with connective tissue, and there were also foci of newly formed bone tissue at the periphery in contact with the rat bone (Figure 1).

Figure 1. Histological study of a critical-size rat calvarial bone defect after implantation. (Vasilyev A V, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
A trusted partner!

These adenoviral particles reliably expressed BMP2 in our mesenchymal stem cells, enhancing osteogenic differentiation. A trusted partner!

United States

07/15/2025

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction